Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model
- Resource Type
- Article
- Source
- In
Cancer Letters 2006 238(2):197-201 - Subject
- Language
- ISSN
- 0304-3835